ALB and esophageal varices: The prevalence of CHE was 50.0% (47 of 94) for patients with serum albumin < 3.7 g/dL and esophageal varices, 52.2% (59 of 113) for those with serum 25(OH)D3 < 16.5 ng/mL and esophageal varices, 53.8% (50 of 93) for those with serum albumin < 3.7 g/dL and serum 25(OH)D3 < 16.5 ng/mL, and 66.7% (40 of 66) for those with all three risk factors.